Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation

Nucleic Acids Research

Volumn 40, Issue 11, 2012, Pages

  Whale, Alexandra S ^a   Huggett, Jim F ^a   Cowen, Simon ^a   Speirs, Valerie ^b   Shaw, Jacqui ^c   Ellison, Stephen ^a   Foy, Carole A ^a   Scott, Daniel J ^a  

^a LGC   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL FREE SYSTEM; CONTROLLED STUDY; COPY NUMBER VARIATION; DIGITAL POLYMERASE CHAIN REACTION; DNA DETERMINATION; DNA REPLICATION; DNA TEMPLATE; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HER2 GENE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MICROFLUIDIC ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ACCURACY; EPIDERMAL GROWTH FACTOR RECEPTOR 2 GENE; GENE EXPRESSION PROFILING; GENETIC MODEL; PREDICTION; PROCESS DEVELOPMENT; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR GENE;

CELL LINE, TUMOR; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 84862205836     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks203     Document Type: Article

References (49)

1. Shlien, A. and Malkin, D. (2010) Copy number variations and cancer susceptibility. Curr. Opin. Oncol., 22, 55-63.
2. Wain, L.V., Armour, J.A. and Tobin, M.D. (2009) Genomic copy number variation, human health, and disease. Lancet, 374, 340-350.
3. McCarroll, S.A. and Altshuler, D.M. (2007) Copy-number variation and association studies of human disease. Nat. Genet., 39, S37-S42. (Pubitemid 47014474)
4. Reese, D.M. and Slamon, D.J. (1997) HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells, 15, 1-8. (Pubitemid 27057075)
5. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. and McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182. (Pubitemid 17231334)
6. Shlien, A. and Malkin, D. (2009) Copy number variations and cancer. Genome Med., 1, 62.
7. Ionita-Laza, I., Rogers, A.J., Lange, C., Raby, B.A. and Lee, C. (2009) Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics, 93, 22-26.
8. Lee, C., Iafrate, A.J. and Brothman, A.R. (2007) Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat. Genet., 39, S48-S54. (Pubitemid 47014476)
9. Xie, C. and Tammi, M.T. (2009) CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinform., 10, 80.
10. Zhang, F., Gu, W., Hurles, M.E. and Lupski, J.R. (2009) Copy number variation in human health, disease, and evolution. Annu. Rev. Genom. Hum. Genet., 10, 451-481.
11. Chiu, R.W., Murphy, M.F., Fidler, C., Zee, B.C., Wainscoat, J.S. and Lo, Y.M. (2001) Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin. Chem., 47, 667-672. (Pubitemid 32275809)
12. Zimmermann, B., Holzgreve, W., Wenzel, F. and Hahn, S. (2002) Novel real-time quantitative PCR test for trisomy 21. Clin. Chem., 48, 362-363. (Pubitemid 34107277)
13. Leon, S.A., Shapiro, B., Sklaroff, D.M. and Yaros, M.J. (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37, 646-650. (Pubitemid 8051621)
14. Stroun, M., Anker, P., Lyautey, J., Lederrey, C. and Maurice, P.A. (1987) Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 23, 707-712. (Pubitemid 17119706)
15. Hahn, S., Jackson, L.G., Kolla, V., Mahyuddin, A.P. and Choolani, M. (2009) Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev. Mol. Diagn., 9, 613-621.
16. Levenson, V.V. (2007) Biomarkers for early detection of breast cancer: what, when, and where? Biochim. Biophys. Acta, 1770, 847-856. (Pubitemid 46617032)
17. Fleischhacker, M. and Schmidt, B. (2007) Circulating nucleic acids (CNAs) and cancer: a survey. Biochim. Biophys. Acta, 1775, 181-232. (Pubitemid 44911084)
18. Jung, K., Fleischhacker, M. and Rabien, A. (2010) Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin. Chim. Acta, 411, 1611-1624.
19. Page, K., Hava, N., Ward, B., Brown, J., Guttery, D.S., Ruangpratheep, C., Blighe, K., Sharma, A., Walker, R.A., Coombes, R.C. et al. (2011) Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br. J. Cancer, 104, 1342-1348.
20. Qin, J., Jones, R.C. and Ramakrishnan, R. (2008) Studying copy number variations using a nanofluidic platform. Nucleic Acids Res., 36, e116.
21. Weaver, S., Dube, S., Mir, A., Qin, J., Sun, G., Ramakrishnan, R., Jones, R.C. and Livak, K.J. (2010) Taking qPCR to a higher level: analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods, 50, 271-276.
22. Fournie, G.J., Gayral-Taminh, M., Bouche, J.P. and Conte, J.J. (1986) Recovery of nanogram quantities of DNA from plasma and quantitative measurement using labeling by nick translation. Anal. Biochem., 158, 250-256. (Pubitemid 17200610)
23. Giacona, M.B., Ruben, G.C., Iczkowski, K.A., Roos, T.B., Porter, D.M. and Sorenson, G.D. (1998) Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas, 17, 89-97. (Pubitemid 28293013)
24. Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L.A. Jr, Goodman, S.N., David, K.A., Juhl, H. et al. (2005) Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc. Natl Acad. Sci. USA, 102, 16368-16373. (Pubitemid 41688920)
25. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L. et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 55, 611-622.
26. Dube, S., Qin, J. and Ramakrishnan, R. (2008) Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One, 3, e2876.
27. Fryer, J.F., Baylis, S.A., Gottlieb, A.L., Ferguson, M., Vincini, G.A., Bevan, V.M., Carman, W.F. and Minor, P.D. (2008) Development of working reference materials for clinical virology. J. Clin. Virol., 43, 367-371.
28. Bhat, S., Herrmann, J., Armishaw, P., Corbisier, P. and Emslie, K.R. (2009) Single molecule detection in nanofluidic digital array enables accurate measurement of DNA copy number. Anal. Bioanal. Chem., 394, 457-467.
29. Sanders, R., Huggett, J.F., Bushell, C.A., Cowen, S., Scott, D.J. and Foy, C.A. (2011) Evaluation of digital PCR for absolute DNA quantification. Anal. Chem., 83, 6474-6484.
30. Dinh, P., de Azambuja, E., Cardoso, F. and Piccart-Gebhart, M.J. (2008) Facts and controversies in the use of trastuzumab in the adjuvant setting. Nat. Clin. Pract. Oncol., 5, 645-654.
31. Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M. et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med., 344, 783-792. (Pubitemid 32222155)
32. Fan, H.C. and Quake, S.R. (2007) Detection of aneuploidy with digital polymerase chain reaction. Anal. Chem., 79, 7576-7579. (Pubitemid 47606128)
33. Hughes, P., Marshall, D., Reid, Y., Parkes, H. and Gelber, C. (2007) The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques, 43, 575-584.
34. Fitzgerald, T.L., Kazan, K., Li, Z., Morell, M.K. and Manners, J.M. (2010) A high-throughput method for the detection of homologous gene deletions in hexaploid wheat. BMC Plant. Biol., 10, 264.
35. Hatch, A.C., Fisher, J.S., Tovar, A.R., Hsieh, A.T., Lin, R., Pentoney, S.L., Yang, D.L. and Lee, A.P. (2011) 1-Million droplet array with wide-field fluorescence imaging for digital PCR. Lab Chip, 11, 3838-3845.
36. Hindson, B.J., Ness, K.D., Masquelier, D.A., Belgrader, P., Heredia, N.J., Makarewicz, A.J., Bright, I.J., Lucero, M.Y., Hiddessen, A.L., Legler, T.C. et al. (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem., 83, 8604-8610.
37. Kreutz, J.E., Munson, T., Huynh, T., Shen, F., Du, W. and Ismagilov, R.F. (2011) Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR. Anal. Chem., 83, 8158-8168.
38. Pinheiro, L.B., Coleman, V.A., Hindson, C.M., Herrmann, J., Hindson, B.J., Bhat, S. and Emslie, K.R. (2012) Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal. Chem., 84, 1003-1011.
39. Devonshire, A.S., Elaswarapu, R. and Foy, C.A. (2011) Applicability of RNA standards for evaluating RT-qPCR assays and platforms. BMC Genom., 12, 118.
40. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
41. Konigshoff, M., Wilhelm, J., Bohle, R.M., Pingoud, A. and Hahn, M. (2003) HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue. Clin. Chem., 49, 219-229. (Pubitemid 36143442)
42. Winnard, P. Jr, Glackin, C. and Raman, V. (2006) Stable integration of an empty vector in MCF-7 cells greatly alters the karyotype. Cancer Genet. Cytogenet., 164, 174-176. (Pubitemid 43129768)
43. Sestini, R., Orlando, C., Zentilin, L., Lami, D., Gelmini, S., Pinzani, P., Giacca, M. and Pazzagli, M. (1995) Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin. Chem., 41, 826-832.
44. Lyon, E., Millson, A., Lowery, M.C., Woods, R. and Wittwer, C.T. (2001) Quantification of HER2/neu gene amplification by competitive pcr using fluorescent melting curve analysis. Clin. Chem., 47, 844-851. (Pubitemid 32398035)
45. Millson, A., Suli, A., Hartung, L., Kunitake, S., Bennett, A., Nordberg, M.C., Hanna, W., Wittwer, C.T., Seth, A. and Lyon, E. (2003) Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification. J. Mol. Diagn., 5, 184-190. (Pubitemid 36974730)
46. Dati, C., Antoniotti, S., Taverna, D., Perroteau, I. and De Bortoli, M. (1990) Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene, 5, 1001-1006.
47. Hynes, N.E., Gerber, H.A., Saurer, S. and Groner, B. (1989) Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J. Cell Biochem., 39, 167-173. (Pubitemid 19062782)
48. Kallioniemi, O.P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L.C., Smith, H.S., Waldman, F.M., Pinkel, D. and Gray, J.W. (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl Acad. Sci. USA, 89, 5321-5325.
49. Pauletti, G., Godolphin, W., Press, M.F. and Slamon, D.J. (1996) Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene, 13, 63-72. (Pubitemid 26248546)